Literature DB >> 22897619

The prevalence of Peyronie's disease in Japan: a study in men undergoing maintenance hemodialysis and routine health checks.

Koji Shiraishi1, Tomoyuki Shimabukuro, Hideyasu Matsuyama.   

Abstract

INTRODUCTION: The incidence of Peyronie's disease (PD) in the general population is believed to be as high as 20%. However, most of the data concerning the prevalence of PD have been obtained from Caucasian populations. AIM: The aim of this study was to examine the prevalence of PD in Asia and among men undergoing hemodialysis and discuss the pathophysiology of PD.
METHODS: A total of 1,090 men who received a routine health check at our hospital (control group) as well as 130 male patients undergoing maintenance hemodialysis were enrolled. The diagnosis of PD was based on a palpable penile plaque. MAIN OUTCOME MEASURES: Hemodialysis patients were asked about their sexual activity and completed the International Index of Erectile Function-5 questionnaires. The differences between patients' and hemodialysis-associated factors, comorbidities, and medications were statistically assessed for patients with and without PD.
RESULTS: The prevalence of PD was significantly increased among hemodialysis patients (12 patients: 9.2%) relative the control group (six men: 0.6%) (P<0.0001, odds ratio: 18.4). In both groups, the plaques were primarily allocated dorsally. In the hemodialysis patients with PD, the frequency of masturbation (P<0.05) and the incidence of moderate or severe erectile dysfunction (P<0.01) were significantly higher than those among hemodialysis patients without PD. In comparison with patients without PD, the number of acetate dialysate users was significantly higher among patients with PD (P<0.05), and none of the PD patients used angiotensin-related antihypertensive drugs (P<0.05).
CONCLUSIONS: The prevalence of PD in healthy Japanese men is low (0.6%), which suggests the existence of racial differences in the prevalence of PD. Moreover, these results indicate that hemodialysis increases the incidence of PD. The differences in the characteristics between male hemodialysis patients with and without PD provide new insights into the pathophysiology and therapeutic window of PD.
© 2012 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22897619     DOI: 10.1111/j.1743-6109.2012.02868.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  7 in total

Review 1.  Outcomes of Surgery in Peyronie's Disease Following Intralesional Collagenase Clostridium Histolyticum Injections.

Authors:  Mahdi Bazzi; Marcus L Jamil; Ali A Dabaja
Journal:  Curr Urol Rep       Date:  2019-06-14       Impact factor: 3.092

Review 2.  The Natural History of Peyronie's Disease.

Authors:  Fabrizio Di Maida; Gianmartin Cito; Luca Lambertini; Francesca Valastro; Girolamo Morelli; Andrea Mari; Marco Carini; Andrea Minervini; Andrea Cocci
Journal:  World J Mens Health       Date:  2020-07-08       Impact factor: 5.400

3.  The Prevalence of Peyronie's Disease in the United States: A Population-Based Study.

Authors:  Mark Stuntz; Anna Perlaky; Franka des Vignes; Tassos Kyriakides; Dan Glass
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

Review 4.  Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option.

Authors:  Andrew T Gabrielson; Laith M Alzweri; Wayne Jg Hellstrom
Journal:  World J Mens Health       Date:  2017-09-06       Impact factor: 5.400

5.  Prevalence, Risk Factors, and Erectile Dysfunction Associated With Peyronie's Disease Among Men Seeking Urological Care.

Authors:  Antonio Segundo; Sidney Glina
Journal:  Sex Med       Date:  2020-01-30       Impact factor: 2.491

6.  Increased Risk of Cancer in Men With Peyronie's Disease: A Cohort Study Using a Large United States Insurance Claims Database.

Authors:  Alexander W Pastuszak; Nannan Thirumavalavan; Taylor P Kohn; Larry I Lipshultz; Michael L Eisenberg
Journal:  Sex Med       Date:  2019-09-14       Impact factor: 2.491

Review 7.  A review of the epidemiology and treatment of Peyronie's disease.

Authors:  Kevin A Ostrowski; John R Gannon; Thomas J Walsh
Journal:  Res Rep Urol       Date:  2016-04-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.